BMY
Bristol-Myers Squibb·NYSE
--
--(--)
--
--(--)
BMY fundamentals
Bristol-Myers Squibb (BMY) Revenue Breakdown: Q4 2025 Business & Regional Performance
Bristol-Myers Squibb (BMY) reported total revenue of 12.50B USD in Q4 2025, with its core business segment Opdivo contributing 21.54%. Regionally, United States remained the largest market, accounting for 68.45% of total revenue. Explore Bristol-Myers Squibb's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Bristol-Myers Squibb (BMY) reported total revenue of 12.50B USD in Q4 2025, with its core business segment Opdivo contributing 21.54%. Regionally, United States remained the largest market, accounting for 68.45% of total revenue. Explore Bristol-Myers Squibb's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Bristol-Myers Squibb's earnings call?What factors drove the changes in Bristol-Myers Squibb's revenue and profit?What is Bristol-Myers Squibb's gross profit margin?What guidance did Bristol-Myers Squibb's management provide for the next earnings period?Did Bristol-Myers Squibb beat or miss consensus estimates last quarter?What is Bristol-Myers Squibb's latest dividend and current dividend yield?What does Bristol-Myers Squibb do and what are its main business segments?What is the market's earnings forecast for Bristol-Myers Squibb next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
